LPXN and prostate carcinoma: Recently, we demonstrated elevated expression levels of LPXN in approximately 20% of prostate cancer patients and showed that knockdown of LPXN by RNAi reduces migration and invasion of PC-3 and DU 145 PCa cell lines [7].